(5S)-5-(triphenylmethyloxymethyl)oxazolidin-2-one | 330555-60-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: (5S)-5-(triphenylmethyloxymethyl)oxazolidin-2-one
• 英文别名: (S)-5-triphenylmethoxymethyl-1,3-oxazolidin-2-one；(S)-5-(trityloxymethyl)oxazolidin-2-one；(S)-5-trityloxymethyl-2-oxazolidinone；2-Oxazolidinone, 5-[(triphenylmethoxy)methyl]-, (5S)-；(5S)-5-(trityloxymethyl)-1,3-oxazolidin-2-one
• CAS: 330555-60-7
• 化学式: C₂₃H₂₁NO₃
• 分子量: 359.425
• InChiKey: NONOANCJDOAYFL-NRFANRHFSA-N

物化性质

• 沸点：
  552.1±19.0 °C(Predicted)
• 密度：
  1.182±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (5S)-5-(triphenylmethyloxymethyl)oxazolidin-2-one 在 对甲苯磺酸 作用下， 以 甲醇 为溶剂， 以88%的产率得到(5S)-5-(羟甲基)-1,3-恶唑烷-2-酮
  参考文献：
  名称：

  Lipase-mediated resolution of 3-hydroxy-4-trityloxybutanenitrile: synthesis of 2-amino alcohols, oxazolidinones and GABOB

  摘要：

  Lipase-mediated kinetic resolution of 3-hydroxy-4-trityloxybutanenitrile gave the (S)-alcohol and (R)-acetate in good yields and high enantioselectivities. The resolution using Pseudomonas cepacia lipase (Burkholderia cepacia) immobilized on modified ceramic particles (PS-C) in diisopropyl ether gave the best results. The use of base additives in this transesterification drastically reduces the reaction time without effecting the yields or enantioselectivities. Resolved 3-hydroxy-4-trityloxybutanenitrile has been utilized for the synthesis of enantiomerically pure 5-tosyloxymethyl-1,3-oxazolidine-2-one, which is an important intermediate for the preparation of beta-adrenergic blocking agents and oxazolidinone based antimicrobial agents. Enantiomerically pure (R)-3-hydroxy-4-trityloxybutanenitrile and (S)-5-tosyloxymethyl-1,3-oxazolidine-2-one have been utilized in the enantioconvergent synthesis of (R)-GABOB. (c) 2006 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tetasy.2006.04.019
• 作为产物：
  描述：

  (3S)-3-hydroxy-4-O-triphenylmethyloxybutanoic acid 在 三乙胺 、 氯甲酸异丁酯 、 sodium azide 作用下， 以 四氢呋喃 、 水 、 甲苯 为溶剂， 反应 4.0h， 以30%的产率得到(5S)-5-(triphenylmethyloxymethyl)oxazolidin-2-one
  参考文献：
  名称：

  Synthesis of homochiral tetrahydropteridines

  摘要：

  A synthesis of protected homochiral tetrahydropteridines from (2S)-malic acid has been developed. This presents methodology for the synthesis of reduced pteridine coenzymes and pharmaceuticals. (C) 2014 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tet.2014.06.048

文献信息

• Biologically active compounds
  申请人：Quibell Martin

  公开号：US20060100431A1

  公开（公告）日：2006-05-11

  Compounds of general formula (I) wherein Z=CR 3 R 4 , where R 3 and R 4 are independently chosen from C 0-7 -alkyl P 1 =CR 5 R 6 , P 2 =O, CR 7 R 8 or NR 9 , Y=CR 10 R 11 —C(O) or CR 10 R 11 —C(S) or CR 10 R 11 —S(O) or CR 10 R 11 —SO 2 (X) 0 =.CR 16 R 17 (W) n =0 , S, C(O), S(O) or S(O) 2 — or NR 18 (V) m =C(O), C(S), S(O), S(O) 2 , S(O) 2 NH, OC(O), NHC(O), NHS(O), NHS(O) 2 , OC(O)NH, C(O)NH or CR 19 R 20 , C═N—C(O)—OR 19 or C═N═C(O)—NHR 19 , U=a stable. 5- to 7 membered monocyclic or a stable 8- to 11-membered bicyclic ring which is either saturated or unsaturated, and which includes zero to four heteroatoms and their sales, hydrates, solvates, complexes and prodruges are inhibitors of cathepsin K and other cysteine protease inhibitors and are useful as therapeutic agents, for example in osteoporosis, Paget's disease gingival diseases such as gingivitis and periodontis, hypercalaemia of malignancy, metabolic bone disease, diseases involving matrix or cartilage degradation, in particular osteoarthitis and rheumatoid arthritis and neoplastic diseases. The compounds are also useful for validating therapeutic target compounds.

  通式(I)的化合物，其中Z=CR3R4，其中R3和R4独立地选择自C0-7烷基；P1=CR5R6，P2=O，CR7R8或NR9；Y=CR10R11—C（O）或CR10R11—C（S）或CR10R11—S（O）或CR10R11—SO2（X）0=.CR16R17（W）n=0、S、C（O）、S（O）或S（O）2—或NR18（V）m=C（O）、C（S）、S（O）、S（O）2、S（O）2NH、OC（O）、NHC（O）、NHS（O）2、OC（O）NH、C（O）NH或CR19R20、C═N—C（O）—OR19或C═N═C（O）—NHR19；U=稳定的5-至7-成员单环或稳定的8-至11-成员双环，它可以是饱和或不饱和，并且可以包含零到四个杂原子，以及它们的盐、水合物、溶剂合物、配合物和前药是猫hepsin K和其他半胱氨酸蛋白酶抑制剂，可用作治疗剂，例如在骨质疏松症、帕吉特病、牙龈疾病如牙龈炎和牙周炎、恶性高钙血症、代谢性骨病、涉及基质或软骨降解的疾病，特别是骨关节炎和类风湿性关节炎和肿瘤性疾病。这些化合物也可用于验证治疗靶点化合物。
• Enantioconvergent chemoenzymatic synthesis of (R)-gamma-amino-beta-hydroxybutyric acid ((R)-GABOB)
  申请人：Kamal Ahmed

  公开号：US20060141606A1

  公开（公告）日：2006-06-29

  The present invention particularly relates to a chemoenzymatic process for the stereoselective preparation of both enantiomers of 3-hydroxy-4-trityloxy butanenitrile key intermediates for the preparation of (R)-GABOB by lipase mediated kinetic resolution of its racemates and their effective application in the enantioconvergent synthesis of (R)-GABOB.

  本发明特别涉及一种化学酶法过程，用于立体选择性制备3-羟基-4-三苄氧基丁腈的两个对映体，该中间体是通过脂肪酶介导的拆分其外消旋体制备(R)-GABOB的关键中间体，并且有效地应用于(R)-GABOB的对映体转化合成中。
• Process for the preparation of oxazolidinones and method of use thereof
  申请人：Hollingsworth I. Rawle

  公开号：US20070265451A1

  公开（公告）日：2007-11-15

  A process for preparing N-(substituted)-C-(substituted methyl)-oxazolidinones, C-(substituted methyl)-oxazolidinones, and N-(substituted)-C-(substituted methyl)-oxazolidinones, preferably chiral, from optically active C-(protected oxymethyl)-oxazolidinones is described. The process can be used to produce combinatorial libraries of the above substituted oxazolidinones in a two or three step reaction comprising a plurality of reagents differing in numbers of carbons or particular substituted oxazolidinones. A number of substituted oxazolidinones produced using the above process have been discovered to have antimicrobial activity.

  本文介绍了一种从光学活性的C-（保护的氧甲基）-噁唑烷酮制备N-（取代）-C-（取代甲基）-噁唑烷酮、C-（取代甲基）-噁唑烷酮和N-（取代）-C-（取代甲基）-噁唑烷酮的方法，其中优选手性化合物。该方法可用于在包含多种碳数或特定取代噁唑烷酮的多种试剂的两步或三步反应中产生上述取代噁唑烷酮的组合库。使用上述方法生产的许多取代噁唑烷酮已被发现具有抗微生物活性。
• PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF
  申请人：Hollingsworth Rawle I.

  公开号：US20080146458A1

  公开（公告）日：2008-06-19

  Substituted oxazolidinone of the formula: wherein R 2 is alkyl selected from the group consisting of methyl, ethyl, and isopropyl moieties, are described. The compounds are antibacterial.

  描述了以下化学式的氧杂环丙酮类替代物：其中R2是选择自甲基，乙基和异丙基基团的烷基。这些化合物具有抗菌作用。
• Synthesis of chiral 2-oxazolidinones, 2-oxazolines, and their analogs
  作者：Jean-Rene Ella-Menye、Guijun Wang

  DOI：10.1016/j.tet.2007.07.044

  日期：2007.10

  Chiral five-membered ring 2-oxazolidinones and six-membered ring 1,3-oxazinan-2-ones are synthesized from the corresponding amino alcohols with complete inversion or retention of stereochemistry. Chiral 5-substituted 2-oxazolines and 6-substituted 2-oxazines are also synthesized from the same starting materials with inversion of stereochemistry through an intramolecular SN2 reaction. These compounds

  由相应的氨基醇合成具有手性的五元环2-恶唑烷酮和六元环1,3-恶二酮-2-酮，并完全反转或保留立体化学。手性5-取代的2-恶唑啉和6-取代的2-恶嗪也从与立体化学的反转相同的原料合成，通过分子内小号Ñ 2反应。这些化合物是有机合成中有用的中间体，是许多药物化合物的重要组成部分。